BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21557394)

  • 21. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
    Pathak S; Grillo AR; Scarpa M; Brun P; D'Incà R; Nai L; Banerjee A; Cavallo D; Barzon L; Palù G; Sturniolo GC; Buda A; Castagliuolo I
    Exp Mol Med; 2015 May; 47(5):e164. PubMed ID: 25998827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB.
    Yang Y; Ma Y; Shi C; Chen H; Zhang H; Chen N; Zhang P; Wang F; Yang J; Yang J; Zhu Q; Liang Y; Wu W; Gao R; Yang Z; Zou Y; Qin H
    Biochem Biophys Res Commun; 2013 May; 434(4):746-52. PubMed ID: 23583411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bax is downregulated in inflamed colonic mucosa of ulcerative colitis.
    Iimura M; Nakamura T; Shinozaki S; Iizuka B; Inoue Y; Suzuki S; Hayashi N
    Gut; 2000 Aug; 47(2):228-35. PubMed ID: 10896914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα.
    Feng X; Wang H; Ye S; Guan J; Tan W; Cheng S; Wei G; Wu W; Wu F; Zhou Y
    PLoS One; 2012; 7(12):e52782. PubMed ID: 23285182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Pekow J; Hutchison AL; Meckel K; Harrington K; Deng Z; Talasila N; Rubin DT; Hanauer SB; Hurst R; Umanskiy K; Fichera A; Hart J; Dinner AR; Bissonnette M
    Inflamm Bowel Dis; 2017 Aug; 23(8):1328-1337. PubMed ID: 28594651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
    PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G
    Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of miR-19a targeting TNF-α in mediating ulcerative colitis.
    Chen B; She S; Li D; Liu Z; Yang X; Zeng Z; Liu F
    Scand J Gastroenterol; 2013 Jul; 48(7):815-24. PubMed ID: 23795660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor.
    Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y
    Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis.
    Takagi T; Naito Y; Mizushima K; Hirata I; Yagi N; Tomatsuri N; Ando T; Oyamada Y; Isozaki Y; Hongo H; Uchiyama K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S129-33. PubMed ID: 20586854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
    Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
    J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
    Yang L; Levi E; Du JH; Zhou HH; Miller R; Majumdar AP
    Colorectal Dis; 2016 Jun; 18(6):O185-93. PubMed ID: 27153478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-141 Is Involved in Ulcerative Colitis Pathogenesis via Aiming at CXCL5.
    Cai M; Chen S; Hu W
    J Interferon Cytokine Res; 2017 Sep; 37(9):415-420. PubMed ID: 28854064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer.
    Dougherty U; Mustafi R; Zhu H; Zhu X; Deb D; Meredith SC; Ayaloglu-Butun F; Fletcher M; Sanchez A; Pekow J; Deng Z; Amini N; Konda VJ; Rao VL; Sakuraba A; Kwesi A; Kupfer SS; Fichera A; Joseph L; Hart J; He F; He TC; West-Szymanski D; Li YC; Bissonnette M
    Epigenetics; 2021 Dec; 16(12):1317-1334. PubMed ID: 33356812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
    Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
    Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
    Rosen MJ; Frey MR; Washington MK; Chaturvedi R; Kuhnhein LA; Matta P; Revetta FL; Wilson KT; Polk DB
    Inflamm Bowel Dis; 2011 Nov; 17(11):2224-34. PubMed ID: 21308881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
    Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
    Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.